UBS Group
TVGNW icon

UBS Group’s Tevogen Inc. Warrant TVGNW Stock Holding History

UBS Group’s Portfolio TVGNW Stock Details TVGNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-328
Closed -$18 – 11287
2025
Q3 		$18 Sell
328
-1,059
-76% -$65 ﹤0.01% 10149
2025
Q2 		$97 Sell
1,387
-16,177
-92% -$898 ﹤0.01% 10009
2025
Q1 		$948 Buy
+17,564
New +$1.25K ﹤0.01% 9609
2024
Q2 		– Sell
-50
Closed -$4 – 10211
2024
Q1 		$4 Buy
+50
New +$3 ﹤0.01% 9158
2023
Q1 		– Sell
-17,377
Closed -$130 – 10517
2022
Q4 		$130 Buy
+17,377
New +$506 ﹤0.01% 10366

Other funds holding TVGNW

FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
GCM
Greenland Capital Management New York $787M AUM 40.68% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

UBS Group's TVGNW Position: Q4 2025 in Review

UBS Group sold out of Tevogen Inc. Warrant (TVGNW) in Q4 2025, closing a stake of 328 shares — an estimated $18 sold.

UBS Group first reported a position in TVGNW in Q4 2022 and held it in 5 quarters. The position peaked at $948 in Q1 2025. 31 funds tracked by Wall St. Rank hold TVGNW as of Q4 2025.

  • UBS Group reported no remaining Tevogen Inc. Warrant position as of Q4 2025 after selling out during the quarter.
  • UBS Group sold 328 Tevogen Inc. Warrant shares in Q4 2025, an estimated $18.
  • UBS Group first reported a position in Tevogen Inc. Warrant in Q4 2022 and held it in 5 quarters.
  • UBS Group's Tevogen Inc. Warrant position peaked at $948 in Q1 2025.
  • 31 funds tracked by Wall St. Rank held Tevogen Inc. Warrant as of Q4 2025.

Based on UBS Group's 13F filing for Q4 2025, filed 29 Jan 2026.